Publicaciones en colaboración con investigadores/as de Hospitais da Universidade de Coimbra (67)

2024

  1. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  2. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  3. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  4. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma

    Gastroenterology, Vol. 166, Núm. 5, pp. 886-901.e7

  5. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  6. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615

  7. NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study

    Journal of Neurology, Neurosurgery and Psychiatry

2023

  1. Altered plasma protein profiles in genetic FTD – a GENFI study

    Molecular Neurodegeneration, Vol. 18, Núm. 1

  2. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  3. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  4. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

    Neurobiology of Disease, Vol. 179

  5. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

    Movement Disorders, Vol. 38, Núm. 2, pp. 286-303

  6. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (The journal of nutrition, health & aging, (2017), 21, 1, (92-104), 10.1007/s12603-016-0803-1)

    Journal of Nutrition, Health and Aging

  7. Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: Comparison with sporadic primary progressive aphasia

    Brain Communications, Vol. 5, Núm. 2

  8. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  9. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1573-1586

  10. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells

    Journal of Hepatology, Vol. 78, Núm. 2, pp. 364-375

  11. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  12. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

    Brain, Vol. 146, Núm. 1, pp. 321-336

  13. Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

    Brain : a journal of neurology, Vol. 146, Núm. 5, pp. 2120-2131